Abstract
Background
Lymphoblastic lymphoma (LBL) is a highly aggressive lymphoma, for which intensive chemotherapy is necessary. This study was designed to evaluate the efficacy and toxicity of a modified acute lymphoblastic leukemia (ALL)-Berlin-Frankfurt-Münster (BFM)-90-based protocol in Chinese children and adolescents with LBL.
Methods
From March 1998 to November 2006, 60 untreated patients with LBL (age <18 years) from a single institution were enrolled. All patients were treated with the modified ALL-BFM-90 protocol, and prophylactic cranial radiotherapy was omitted.
Results
The median age of the patients was 10 years (range, 2.5–18 years). Forty-eight (80%) patients had T-cell LBL, and 59 (98.3%) of the patients were stage III/IV. At the end of induction remission Ia (day 33), 3 patients had died of treatment-related toxicity. In the remaining 57 patients, complete remission (CR) or CR undetermined (CRu) had occurred in 47 (82.45%), who were designated as the moderate-risk group and partial remission (PR) had occurred in 10 patients (17.54%), who were designated the high-risk group. All patients experienced grade 3–4 hematological toxicity. At a median follow-up of 35 months, event-free survival was 78.81% ± 0.05 for all patients; the figure was 88.34% ± 0.05 for the moderate-risk group (90.91% ± 0.08 for stage III, 87.68% ± 0.06 for stage IV, 100% for those with B-cell LBL, 84.78% ± 0.06 for those with T-cell LBL, and 82.94% ± 0.08 for stage IV patients with more than 25% blast cells in bone marrow [BM]). The event-free survival in the high-risk group was 60% ± 0.15.
Conclusion
This modified ALL-BFM-90 protocol is an effective regimen and it greatly improved the survival rate of Chinese children and adolescents with LBL compared with the ALL protocols used previously.
Similar content being viewed by others
References
Anderson JR, Jenkin RD, Wilson JF, et al. (1993) Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin’s lymphoma: a report of CCG-551 from the Children’s Cancer Group. J Clin Oncol 11:1024–1032
Kaiser U, Uebelacker I, Havemann K (1999) Non-Hodgkin’s lymphoma protocols in the treatment of patients with Burkitt’s lymphoma and lymphoblastic lymphoma: a report on 58 patients. Leuk Lymphoma 36:101–108
Reiter A, Schrappe M, Ludwig WD, et al. (2000) Intensive ALLtype therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood 95:416–421
Murphy SB (1980) Classification, staging and end results of treatment in childhood non-Hodgkin’s lymphoma: dissimilarities from lymphomas in adults. Semin Oncol 7:332–339
Schrappe M, Reiter A, Ludwig WD, et al. (2000) Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. Blood 95:3310–3322
Hill FG, Richards S, Gibson B, et al. (2004) Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI. Br J Haematol 124:33–46
Kamps WA, Bokkerink JP, Hakvoort-Cammel FG, et al. (2002) BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991-1996). Leukemia 16:1099–1011
Nathan PC, Maze R, Spiegler B, et al. (2004) CNS-directed therapy in young children with T-lineage acute lymphoblastic leukemia: high-dose methotrexate versus cranial irradiation. Pediatr Blood Cancer 42:24–29
Burkhardt B, Woessmann W, Zimmermann M, et al. (2006) Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma. J Clin Oncol 24:491–499
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Sun, XF., Xia, ZJ., Zhen, ZJ. et al. Intensive chemotherapy improved treatment outcome for Chinese children and adolescents with lymphoblastic lymphoma. Int J Clin Oncol 13, 436–441 (2008). https://doi.org/10.1007/s10147-008-0771-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-008-0771-5